2021
Anti‐glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS
Shin J, Geetha D, Szpirt W, Windpessl M, Kronbichler A. Anti‐glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS. Therapeutic Apheresis And Dialysis 2021, 26: 24-31. PMID: 34339589, DOI: 10.1111/1744-9987.13718.Peer-Reviewed Original ResearchConceptsAnti-GBM diseasePlasma exchangePoor prognosisCombination of therapeutic plasma exchangeGoodpasture's diseaseAnti-glomerular basement membrane diseaseAnti-glomerular basement membraneANCA-associated vasculitisPhase II trialStandard of care managementTherapeutic plasma exchangeBasement membrane diseaseLong-term treatmentAnti-GBM antibodiesSevere kidney failureSevere disease phenotypePrognostic factorsII trialMembrane diseasePulmonary hemorrhageEarly initiationRefine treatment approachesKidney failureTreatment approachesPatients
2017
Circulating Monoclonal IgG1-kappa Antibodies Causing Anti-glomerular Basement Membrane Nephritis
Vankalakunti M, Nada R, Kumar A, Patro K, Ramakrishnan S, Rangarajan D. Circulating Monoclonal IgG1-kappa Antibodies Causing Anti-glomerular Basement Membrane Nephritis. Indian Journal Of Nephrology 2017, 27: 327-329. PMID: 28761240, PMCID: PMC5514834, DOI: 10.4103/ijn.ijn_113_16.Peer-Reviewed Original ResearchLife-threatening pulmonary hemorrhageAnti-glomerular basement membraneProgressive renal failureMode of therapyRare monoclonal antibodiesAnti-GBM antibodiesAnti-GBM nephritisWell-characterized causesCause of glomerulonephritisAntibody diseasePulmonary hemorrhageRenal failureGlomerular capillary wallRenal damageEarly diagnosisMonoclonal antibodiesBasement membraneAntibodiesCapillary wallHemoptysisImmunosuppressionPlasmapheresisHemorrhageGlomerulonephritisNephritis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply